#Doc Moyad’s What Works and What is Worthless Column—Provenge�
# Cell Genesis Reports Phase II Results with GVAX Immunotherapy
# A Survivor Reviews the 2007 ASCO Prostate Cancer Symposium
The robotic-assisted laparoscopic prostatectomy is rapidly becoming the
“standard of care” for those who choose surgery.
IMRT (Intensity Modulated Radiation Therapy) is the “standard of care” for
external beam radiation, but there remains an important place for brachytherapy
(radioactive seed implants).
Docetaxel is the “standard of care” for those who need chemotherapy.
# UCSD Researchers Report Ability to Detect Cancer at Earliest, Curable Stage
# New Blood Test for Prostate Cancer—Can EPCA-2 be on the Horizon?
This is an excellent newsletter that included A review of the 2007 ASCO prostate cancer symposium, an update on EPCA-2, a test that will help in screening for prostate cancer and may replace PSA on day as the best screening test, and the significance of PSA doubling time after prostate removal.